13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001335325
Total reported value
$438.6M
$438.6M
137 檔
13.5%
As reported in its official Q2 2024 Form 13F filing, HighVista Strategies LLC's tracked investment portfolio stood at $438.6M with 137 total positions.
During Q2 2024, HighVista Strategies LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DBC | Invesco Db Commodity Index T | ETF-Commodities | 12.19% | -2.02% | — | |
| 2 | INSM | Insmed Inc | Stock-Healthcare | 3.10% | -0.34% | — | |
| 3 | ✓ | Merus N V | Stock-Other | 2.52% | — | -4.08% | |
| 4 | CRM | Salesforce Inc | Stock-Tech | 1.99% | -0.43% | EXIT | |
| 5 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 1.83% | +0.18% | +28.16% | |
| 6 | HCP2EUR | Hashicorp Inc-cl A | Stock-Other | 1.60% | — | — | |
| 7 | HES | Hess CORP | Stock-Other | 1.56% | — | — | |
| 8 | CTLTEUR | Catalent Inc | Stock-Other | 1.55% | — | — | |
| 9 | JNP | Juniper Networks Inc | Stock-Other | 1.53% | — | — | |
| 10 | AKX | Ansys Inc | Stock-Other | 1.50% | — | — | |
| 11 | MSFT | Microsoft CORP | Stock-Tech | 1.50% | -0.45% | -25.29% | |
| 12 | ETRNUSD | Equitrans Midstream CORP | Stock-Other | 1.47% | — | — | |
| 13 | CERE1EUR | Cerevel Therapeutics Holding | Stock-Other | 1.45% | — | — | |
| 14 | ACI | Albertsons Cos Inc - Class A | Stock-Consumer Staples | 1.36% | — | — | |
| 15 | AMED | Amedisys Inc | Stock-Other | 1.32% | — | — | |
| 16 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 1.27% | -0.56% | -10.45% | |
| 17 | INTU | Intuit Inc | Stock-Tech | 1.17% | -0.36% | EXIT | |
| 18 | APGE | Apogee Therapeutics Inc | Stock-Other | 1.13% | -0.83% | EXIT | |
| 19 | BKNG | Booking Holdings Inc | Stock-Consumer Disc | 1.10% | -0.33% | EXIT | |
| 20 | CART | Maplebear Inc | Stock-Consumer Disc | 1.09% | — | +49.02% | |
| 21 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.04% | -0.03% | -2.09% | |
| 22 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 1.04% | -0.30% | — | |
| 23 | ACLXGBX | Arcellx Inc | Stock-Other | 1.03% | — | -29.34% | |
| 24 | XOMA | Xoma Royalty Corporation | Stock-Other | 1.03% | -0.41% | EXIT | |
| 25 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 1.02% | — | — | |
| 26 | ELVN | Enliven Therapeutics Inc | Stock-Other | 1.02% | +0.81% | -5.57% | |
| 27 | XPO | Xpo Inc | Stock-Industrials | 0.99% | -0.03% | -33.61% | |
| 28 | OLMA | Olema Pharmaceuticals Inc | Stock-Other | 0.98% | -0.02% | — | |
| 29 | SYRE | Spyre Therapeutics Inc | Stock-Other | 0.98% | -0.47% | -26.45% | |
| 30 | VRDN | Viridian Therapeutics Inc | Stock-Other | 0.94% | -0.05% | — | |
| 31 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 0.94% | — | -19.61% | |
| 32 | CPRI | Capri Holdings Limited | Stock-Consumer Disc | 0.94% | — | — | |
| 33 | PCVX | Vaxcyte Inc | Stock-Other | 0.89% | -0.02% | +246.67% | |
| 34 | COGT | Cogent Biosciences Inc | Stock-Other | 0.87% | -0.42% | — | |
| 35 | V | Visa Inc-class A Shares | Stock-Financials | 0.86% | -0.13% | — | |
| 36 | FISV | Fiserv Inc | Stock-Other | 0.85% | — | +22.92% | |
| 37 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 0.81% | — | — | |
| 38 | NUVL | Nuvalent Inc-a | Stock-Other | 0.80% | -1.60% | EXIT | |
| 39 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 0.77% | -0.02% | -7.30% | |
| 40 | TMUS | T-mobile US Inc | Stock-Comm Services | 0.77% | — | +25.26% | |
| 41 | META | Meta Platforms Inc-class A | Stock-Comm Services | 0.75% | -0.13% | -8.91% | |
| 42 | PTC | Ptc Inc | Stock-Tech | 0.70% | -0.29% | EXIT | |
| 43 | SWTXUSD | Springworks Therapeutics Inc | Stock-Other | 0.70% | — | — | |
| 44 | MLTX | Moonlake Immunotherapeutics | Stock-Other | 0.68% | -0.17% | -29.31% | |
| 45 | STX | Seagate Technology Holdings plc | Stock-Tech | 0.67% | +0.10% | +39.06% | |
| 46 | AUTL | Autolus Therapeutics PLC | Stock-Other | 0.66% | — | +98.54% | |
| 47 | TVTX | Travere Therapeutics Inc | Stock-Other | 0.66% | +0.82% | — | |
| 48 | EQR | Equity Residential | Stock-Real Estate | 0.66% | — | +18.26% | |
| 49 | KROS | Keros Therapeutics Inc | Stock-Other | 0.65% | — | — | |
| 50 | WDC | Western Digital CORP | Stock-Tech | 0.65% | +0.13% | +19.19% |
According to official SEC Form 13F filings, HighVista Strategies LLC reported a total U.S. public equity portfolio value of $438.6M across 137 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including DBC, INSM, MERUS N V) accounted for 13.5% of total reported equity market value during Q2 2024.
During Q2 2024, HighVista Strategies LLC's top holdings by market value included DBC (12.2%)、INSM (3.1%)、MERUS N V (2.5%). The largest single position, DBC, represented 12.2% of total portfolio value.
In Q2 2024, HighVista Strategies LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.